MN SF831 | 2021-2022 | 92nd Legislature

Status

Spectrum: Partisan Bill (Republican 5-0)
Status: Introduced on February 11 2021 - 25% progression, died in committee
Action: 2021-03-17 - Comm report: To pass and re-referred to Health and Human Services Finance and Policy
Pending: Senate Health and Human Services Finance and Policy Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Prescription drug manufacturer importation pathway plan application and incentives

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription drug manufacturer importation pathway plan application and incentives

Sponsors


History

DateChamberAction
2021-03-17SenateComm report: To pass and re-referred to Health and Human Services Finance and Policy
2021-03-15SenateAuthor added Coleman
2021-03-11SenateComm report: To pass and re-referred to Commerce and Consumer Protection Finance and Policy
2021-02-11SenateReferred to Health and Human Services Finance and Policy
2021-02-11SenateIntroduction and first reading

Same As/Similar To

HF2004 (Similar To) 2021-03-08 - Introduction and first reading, referred to Commerce Finance and Policy

Minnesota State Sources


Bill Comments

feedback